FDA approves Keytruda and Padcev combo for bladder cancer treatment
Go back to FDA approves Keytruda and Padcev combo for bladder cancer treatment| Merck & Co. (NYSE: MRK) | Delayed: 119.60 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $119.60 | 52 Week High | $65.46 | |||
| Open | $119.60 | 52 Week Low | $47.97 | |||
| Day High | $119.60 | P/E | 81.36 | |||
| Day Low | $119.60 | EPS | $1.47 | |||
| Volume | 3,621 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 24.72 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.72 | 52 Week High | $37.39 | |||
| Open | $24.72 | 52 Week Low | $28.25 | |||
| Day High | $24.72 | P/E | 14.98 | |||
| Day Low | $24.72 | EPS | $1.65 | |||
| Volume | 91,341 | |||||
